文献速递鼻科

RANKL是慢性鼻窦炎骨炎的生物标志物

Receptor activator of nuclear factor κB ligand is a biomarker for osteitis of chronic rhinosinusitis.
PubMed 文献 · Int Forum Allergy Rhinol · 2019-11-06

本研究纳入63例伴鼻息肉的慢性鼻窦炎(CRSwNP)患者、8例不伴鼻息肉的慢性鼻窦炎(CRSsNP)患者和12例对照,分析RANKL表达与骨炎的关系。结果发现CRS患者GOSS评分显著高于对照,非嗜酸性CRSwNP的GOSS高于嗜酸性CRSwNP,RANKL mRNA和蛋白水平与GOSS正相关,抗RANKL治疗可减轻小鼠模型黏膜炎症和骨重塑。

要点

  • CRS患者骨炎评分GOSS显著高于对照,非嗜酸性CRSwNP骨炎更重。
  • RANKL表达与GOSS正相关,复发者RANKL/OPG比值高于原发者。
  • 小鼠CRSwNP模型中抗RANKL治疗可减轻黏膜炎症和骨重塑。

核心结论

  • RANKL表达与CRSwNP的临床骨炎及疾病严重程度相关,可能作为CRS的生物标志物和发病关键分子。

研究设计与样本

  • 纳入CRSwNP患者63例、CRSsNP患者8例和对照12例,分析组织学表型、临床信息、CT评分、GOSS及RANKL表达,并用CRS小鼠模型给予抗RANKL治疗。

主要发现

  • 所有CRS患者的GOSS值显著高于对照组。
  • 非嗜酸性CRSwNP的GOSS值高于嗜酸性CRSwNP。
  • CRS中RANKL上调而诱饵受体骨保护素(OPG)下调。
  • RANKL mRNA和蛋白水平与GOSS呈正相关。
  • 复发 cases 的RANKL/OPG比值高于原发 cases,多种炎症介质与RANKL蛋白水平正相关。

关键数值与推荐

  • CRSwNP患者63例,CRSsNP患者8例,对照12例。
  • 小鼠CRSwNP模型中抗RANKL治疗消除了黏膜炎症和骨重塑。

临床怎么用

  • RANKL可能作为评估CRS骨炎和疾病严重程度的潜在生物标志物。
  • 抗RANKL治疗在动物模型中显示减轻炎症和骨重塑的作用,提示潜在治疗方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Evidence of osteitis is frequently observed in patients with chronic rhinosinusitis (CRS), especially in recalcitrant cases. However, studies focusing on biological markers of osteitis are limited and it remains unclear whether osteitis is associated with different phenotypes of CRS. This study aimed to analyze the expression and assess the roles of receptor activator of nuclear factor κB ligand (RANKL) in patients with CRS and osteitis. METHODS: CRS patients with nasal polyps (CRSwNP, n = 63), CRS patients without nasal polyps (CRSsNP, n = 8), and control subjects (n = 12) were enrolled. Histologic phenotypes, clinical information, and computed tomography (CT) scores were investigated. The Global Osteitis Scoring Scale (GOSS) and RANKL, a molecular marker of bone remodeling, were analyzed in each type of CRS. CRS mouse models were treated with anti-RANKL. RESULTS: GOSS values were significantly higher in all CRS patients than in the control group. The GOSS value in non-eosinophilic CRSwNP was higher than in eosinophilic CRSwNP. RANKL was upregulated whereas decoy receptor osteoprotegerin (OPG) was downregulated in CRS. RANKL messenger RNA (mRNA) and protein levels were positively correlated with GOSS. RANKL/OPG was increased in recurrent cases compared with primary cases. Multiple inflammatory mediators were positively correlated with the protein level of RANKL in CRS tissues. In the mouse CRSwNP model, anti-RANKL treatment abrogated mucosal inflammation and bone remodeling. CONCLUSION: RANKL expression is associated with clinical osteitis and disease severity in CRSwNP. These findings shed light on the importance of RANKL as a potential biomarker of CRS and a key player in CRS pathogenesis.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Kong IG, Kim DK, Eun KM, et al. Receptor activator of nuclear factor κB ligand is a biomarker for osteitis of chronic rhinosinusitis. Int Forum Allergy Rhinol. 2019. PMID: 31693309. doi:10.1002/alr.22481

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。